Income tax expense · 2011–2025
Vertex Pharmaceuticals income tax expense
$690M−12.0% · FY2025
Vertex Pharmaceuticals (VRTX) reported $690M in income tax expense for fiscal 2025, −12.0% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $690M | −12.0% | Open → |
| FY20242024-12-31 | $784M | +3.1% | Open → |
| FY20232023-12-31 | $760M | −16.5% | Open → |
| FY20222022-12-31 | $910M | +134.5% | Open → |
| FY20212021-12-31 | $388M | −4.2% | Open → |
| FY20202020-12-31 | $405M | +85.8% | Open → |
| FY20192019-12-31 | $218M | +$1.7B | Open → |
| FY20182018-12-31 | −$1.5B | −$1.4B | Open → |
| FY20172017-12-31 | −$107M | −$124M | Open → |
| FY20162016-12-31 | $16.7M | −45.1% | Open → |
| FY20152015-12-31 | $30.4M | +336.6% | Open → |
| FY20142014-12-31 | $7.0M | +$129M | Open → |
| FY20132013-12-31 | −$122M | −$122M | Open → |
| FY20122012-12-31 | −$275,000 | −$19.5M | Open → |
| FY20112011-12-31 | $19.3M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +29.1%
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Vertex Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/vertex-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Vertex Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/vertex-pharmaceuticals/income-tax-expenseBibTeX
@misc{companiesranked-en-company-vertex-pharmaceuticals-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Vertex Pharmaceuticals income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/vertex-pharmaceuticals/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000875320-26-000056 · February 13, 2026
{{cite web |title=Vertex Pharmaceuticals income tax expense — 10-K (0000875320-26-000056) |url=https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.